Table 1.
Demographics table.
| Statistic | Radiation Alone Results (N = 33) | Chemoradiation Results (N = 47) | p-Value |
|---|---|---|---|
| Median (range) years of age | 73 (65–86) | 74 (65–84) | 0.28 |
| N (%) sex | |||
| Male | 19 (57.6%) | 24 (51.1%) | 0.57 |
| Female | 14 (42.4%) | 23 (48.9%) | |
| N (%) KPS score | |||
| <80 | 18 (54.6%) | 30 (63.3%) | 0.4 |
| ≥80 | 15 (45.4%) | 17 (36.2%) | |
| Median (range) KPS score | 70 (40–90) | 70 (40–90) | 0.77 |
| Median (range) MMSE score | 27 (12–30) | 27 (12–30) | 0.8 |
| N (%) | |||
| Gross total resection | 10 (30.3%) | 9 (19.2%) | 0.51 |
| Subtotal resection | 15 (45.4%) | 25 (53.2%) | |
| Biopsy only | 8 (24.2%) | 13 (27.7%) | |
| Median (range) months Duration of Temozolomide | |||
| Concurrent | - | 0.7 (0.2, 0.8) | NC |
| Maintenance (n = 26) | 4.8 (0.2, 14.8) | ||
| Total | 0.8 (0.2, 15.5) | ||
| N (%) Completed Radiation Treatment | 33 (100.0) | 46 (97.9) | 1 |
| Tumor Location | |||
| Corpus collosal | 1 (3.0) | 1 (2.1) | NC |
| Frontal | 11 (33.3) | 9 (19.1) | |
| Frontoparietal | 2 (6.1) | 4 (8.5) | |
| Frontotemporal | 2 (6.1) | 5 (10.6) | |
| Occipital | 2 (6.1) | 0 (0) | |
| Parietal | 2 (6.1) | 10 (21.3) | |
| Parietooccipital | 2 (6.1) | 3 (6.4) | |
| Temporal | 8 (24.2) | 10 (21.3) | |
| Temporoparietal | 1 (3.0) | 4 (8.5) | |
| Thalamus | 2 (6.1) | 1 (2.1) | |
| Side | |||
| Both | 1 (3.0) | 1 (2.1) | 0.82 |
| Left | 16 (48.4) | 26 (55.3) | |
| Right | 16 (48.4) | 20 (42.6) |